Robyn Murphy

Robyn Murphy is an experienced professional in clinical program management and biostatistics with extensive expertise in the biotechnology and pharmaceutical sectors. Currently serving as the Director of Clinical Program Management at Atara Biotherapeutics since June 2020, Robyn previously held various positions at Amgen from 1996 to June 2020, including Senior Manager of Alliance Management, Senior Project Manager, and Senior Biostatistics Manager. In these roles, Robyn managed key partnerships, led oncology development-stage projects, and provided biostatistics support for multiple therapeutic areas. Additionally, Robyn volunteered as a Business Strategy Advisor for Neuroboxing Parkinson, contributing to the organization's mission and strategic planning. Robyn holds a Master of Science in Biostatistics and a Bachelor of Science in Biomechanics from the University of Massachusetts Amherst.